Sort
16,179 grants matching “malaria”
UCSF HIV Clinical Trials Unit
$6,132,107Diane V Havlir · University Of California, San Francisco · UM1 · FY2012 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,113,687David S Stephens · Emory University · UM1 · FY2023 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,111,537David S Stephens · Emory University · UM1 · FY2024 · AI
Malaria Vaccine Production and Support Services
$6,043,544 · N01 · FY2008 · AI
REGIONAL PRIMATE RESEARCH CENTER
$5,984,645Tulane University Of Louisiana · P51 · FY2001 · RR
Data Coordinating Center for the Sickle Cell Disease Clinical Research Network
$5,928,099Donald Brambilla · New England Research Institutes, Inc. · U10 · FY2007 · HL
DCTD Biopharmaceutical Development
$5,855,121David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Structural Genomics of Pathogenic Protozoa
$5,792,549University Of Washington · P50 · FY2002 · GM
'MALARIA RESEARCH'
$5,766,455National Center For Parasitology Entomology And Malaria Control · · FY2012 · Defense Health Agency
REGIONAL PRIMATE RESEARCH CENTER
$5,731,111Tulane University Of Louisiana · P51 · FY2000 · RR
The J. Craig Venter Institute Genome Center for Infectious Diseases
$5,728,020William Charles Nierman · J. Craig Venter Institute, Inc. · U19 · FY2017 · AI
¿¿DEVELOPMENT OF SAFER DRUGS FOR MALARIA AND LEISHMANIASIS IN US TROOPS, CIVILIAN PERSONNEL AND TRAVELERS¿¿
$5,701,050The University Of Mississippi · · FY2010 · Department of Defense
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine LOC
$5,663,427Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
A Systems Biology Approach to the Model Apicomplexan Toxoplasma gondii
$5,630,177Kami Kim · Albert Einstein College Of Medicine · RC4 · FY2010 · AI
The J. Craig Venter Institute Genome Center for Infectious Diseases
$5,620,569William Charles Nierman · J. Craig Venter Institute, Inc. · U19 · FY2014 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$5,617,284David S Stephens · Emory University · UM1 · FY2022 · AI
The J. Craig Venter Institute Genome Center for Infectious Diseases
$5,595,971William Charles Nierman · J. Craig Venter Institute, Inc. · U19 · FY2018 · AI
Malaria immunology
$5,503,594Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,496,338Bruce W. Birren · Broad Institute, Inc. · U19 · FY2018 · AI
Vaccine Treatment Evaluation Units: Infectious Diseases Clinical ResearchConsortium
$5,485,854Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2020 · AI
Vaccine and Treatment Evaluation Units
$5,485,363Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
$5,445,286Bruce W. Birren · Broad Institute, Inc. · U19 · FY2014 · AI
Assays to Support Development of Malaria Transmission Blocking Vaccines
$5,422,499Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
$5,397,843Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
COOPERATIVE AGREEMENT WITH THE KENYA MEDICAL RESEARCH INSTITUTE (KEMRI)
$5,347,112John Vulule · Kenya Medical Research Institute (Kemri) · U19 · FY2013 · GH